Active Recombinant Mouse Il25
Cat.No. : | Il25-804M |
Product Overview : | Recombinant Mouse Il25 (Accession # NP_542767) Val17-Ala169, fused with with and without an N-terminal Met, was produced in E. coli. |
- Specification
- Gene Information
- Related Products
Source : | E. coli |
Species : | Mouse |
Predicted N Terminal : | Val17 and Met |
Form : | Lyophilized from a 0.2 µm filtered solution in Acetonitrile and TFA with BSA as a carrier protein. |
Bio-activity : | Measured by its ability to induce CXCL1/GRO alpha secretion in HT-29 human colon adenocarcinoma cells.The ED50 for this effect is typically 0.25-1.5 ng/mL. |
Molecular Mass : | Recombinant Mouse Il25, Met-tagged has a calculated MW of 17.6 kDa (monomer). |
Protein length : | Val17-Ala169 |
Purity : | >97%, by SDS-PAGE under reducing conditions and visualized by silver stain. |
Storage : | Avoid repeated freeze-thaw cycles. No activity loss was observed after storage at: In lyophilized state for 1 year (4ºC); After reconstitution under sterile conditions for 3 months (-70ºC). |
Gene Name : | Il25 interleukin 25 [ Mus musculus ] |
Official Symbol : | Il25 |
Synonyms : | IL25; interleukin 25; interleukin-25; interleukin 17E; Il17e; IL-17e; |
Gene ID : | 140806 |
mRNA Refseq : | NM_080729 |
Protein Refseq : | NP_542767 |
MIM : |
Products Types
◆ Recombinant Protein | ||
IL25-166M | Recombinant Mouse IL25 Protein | +Inquiry |
Il25-183M | Recombinant Active Mouse IL25 Protein, His-tagged(C-ter) | +Inquiry |
Il25-8736R | Active Recombinant Rat Il25 protein(Val17-Ala169), hFc-tagged | +Inquiry |
IL25-1031H | Recombinant Human IL25 Protein, His-tagged | +Inquiry |
Il25-1011M | Recombinant Mouse Il25 Protein, MYC/DDK-tagged | +Inquiry |
◆ Lysates | ||
IL25-2910MCL | Recombinant Mouse IL25 cell lysate | +Inquiry |
IL25-2920HCL | Recombinant Human IL25 cell lysate | +Inquiry |
IL25-1261RCL | Recombinant Rat IL25 cell lysate | +Inquiry |
Related Gene
For Research Use Only. Not intended for any clinical use. No products from Creative BioMart may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative BioMart.
Inquiry
- Q&As
- Reviews
Q&As (6)
Ask a questionThere is a lack of conclusive evidence that IL-25 has a clear effect in tumor treatment, but there are some studies underway.
There are no clear studies on the side effects of IL-25, but the patient response needs to be closely monitored during research and clinical application.
In addition to treating asthma and inflammatory bowel disease, IL-25 may also have potential applications in the treatment of lung infections, urticaria and other diseases.
IL-25 activates specific signaling pathways by binding to specific receptors, thereby regulating the activity of immune cells and the degree of inflammation in the body.
Some studies have shown that recombinant IL-25 can improve symptoms of diseases such as asthma and inflammatory bowel disease, but more research is needed to verify its efficacy.
Yes, in general, IL-25 therapy needs to be administered by injection to ensure that the protein can enter the body and work.
Customer Reviews (3)
Write a reviewThe activity is very strong and can meet my research needs.
Price is very reasonable and good value for money.
It is very stable and can be stored and used for a long time.
Ask a Question for All Il25 Products
Required fields are marked with *
My Review for All Il25 Products
Required fields are marked with *
Inquiry Basket